References
- Chen DS. Natural history of chronic HBV infection: new light on an old story. J Gastroenterol Hepatol 1993; 8: 470–5.
- Lok ASF, Chung HT, Liu VW, Ma OC. Long-term fol-low-up of chronic hepatitis B patients treated with interferon alpha. Gastroenterology. 1993; 105: 1833–8.
- Brunetto MR, Giarin M, Saracco G, et al. Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B. Gastroenterology 1993; 105: 845–50.
- Ahmed A, Keeffe EB. Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infec-tion. Am J Gastroenterol 1999; 94: 249–51.
- Chang MH, Hsu HY, Hsu HC, Ni YH, Chen JS, Chen DS. The significance of spontaneous hepatitis B e antigen seroconversion in childhood: with special emphasis on the clearance of hepatitis B e antigen before 3 years of age. Hepatology 1995; 22: 1387-92.
- Demirturk N, Usluer G, Ozgunes I, Colak H, Kartal ED, Dincer S. Comparison of different treatment combinations for chronic hepatitis B infection. J Chemother 2002; 14: 285–9.
- Sokal EM, Conjeevaram HS, Roberts EA, et al. Interferon alpha therapy for chronic hepatitis B in children: a multinational randomized controlled trial. Gastroenterology 1998; 14: 988–95.
- Dikici B, Bosnak M, Ucmak H, Dagli A, Ece A, Haspolat K. Failure of therapeutic vaccination using hepatitis B surface antigen vaccine in the immunotolerant phase of chil-dren with chronic hepatitis B infection. J Gastroenterol Hepatol 2003; 18: 218–22.
- Lau GK, Nanji A, Hou J, et al. Thymosin-alphal and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tol-erant phase. J Viral Hepat 2002; 9: 280–7.
- Wai CT, Lok AS. Treatment of hepatitis B. J Gastroenterol 2002; 37: 771–8.
- Boni C, Bertoletti A, Penna A, et al. Lamivudine treat-ment can restore T-cell responsiveness in chronic hepatitis B. Br J Clin Invest 1998; 102: 968–975.
- Boni C, Penna A, Ogg GS, et al. Lamivudine treat-ment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology 2001; 33: 963–971.
- Keam SJ, Scott II. Lamivudine: in children and adoles-cents with chronic hepatitis B virus infection. Paediatr Drugs 2002; 4: 687–94.